US Stock MarketDetailed Quotes

CLDX Celldex Therapeutics

Watchlist
  • 27.440
  • -0.450-1.61%
Close Nov 29 13:00 ET
  • 26.737
  • -0.703-2.56%
Post 17:02 ET
1.82BMarket Cap-10635P/E (TTM)

About Celldex Therapeutics Company

Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.

Company Profile

SymbolCLDX
Company NameCelldex Therapeutics
Listing DateMay 1, 1986
Founded1983
CEOMr. Anthony S. Marucci
MarketNASDAQ
Employees160
Fiscal Year Ends12-31
AddressPerryville III Building,53 Frontage Road,Suite 220
CityHampton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08827
Phone1-908-454-7120
Websitehttp://www.celldex.com

Company Executives

  • Name
  • Position
  • Salary
  • Anthony S. Marucci
  • Director, President and Chief Executive Officer
  • 8.36M
  • Dr. Ronald A. Pepin, PhD
  • Senior Vice President and Chief Business Officer
  • --
  • Richard M. Wright, PhD
  • Senior Vice President and Chief Commercial Officer
  • --
  • Dr. Diane C. Young, M.D.
  • Senior Vice President and Chief Medical Officer
  • 2.97M
  • Sam Martin
  • Treasurer, Senior Vice President, Secretary, Principal Accounting Officer and Chief Financial Officer
  • 2.95M
  • Dr. Tibor Keler, PhD
  • Executive Vice President and Chief Scientific Officer
  • 3.42M
  • Elizabeth Crowley
  • Senior Vice President and Chief Product Development Officer
  • --
  • Dr. Margo Heath-Chiozzi, M.D.
  • Senior Vice President, Regulatory Affairs
  • 2.94M
  • Freddy A. Jimenez
  • Senior Vice President and General Counsel
  • --
  • Sarah Cavanaugh
  • Senior Vice President, Corporate Affairs and Administration
  • --
  • Karen L. Shoos
  • Chairman of the Board
  • 385.77K
  • Harry H. Penner, Jr
  • Independent Director
  • 371.19K
  • Dr. Rita I. Jain, M.D.
  • Independent Director
  • 599.50K
  • Dr. Garry A. Neil, M.D.
  • Independent Director
  • 366.22K
  • Cheryl L. Cohen
  • Independent Director
  • 367.02K
  • James J. Marino, J.D.,M.B.A.
  • Independent Director
  • 377.44K
  • Keith L. Brownlie
  • Independent Director
  • 373.27K
  • Herbert J. Conrad
  • Independent Director
  • --
  • Herbert J. Conrad
  • Independent Director
  • 364.94K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data